A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as effectively as standard hormone injections in men with locally advanced or ...
Add Yahoo as a preferred source to see more of our stories on Google. A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, experts have said. The treatment, a ...
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
ORLANDO, Fla. (Ivanhoe Newswire) - The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The average age of men who get diagnosed is ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Prostate cancer represents one of the most common malignancies in men in developed countries with increasing incidence in recent years due to the ...
At 77 years old, Tyson Johnson has been in treatment for metastatic prostate cancer for more than 20 years. “I’m the healthiest dead man you’ve ever seen,” the Carthage resident said jokingly as he ...
St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programme Dr Kenrick Ng, Medical Oncology Consultant, St Bartholomew's Hospital, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results